Editor s Note | GenomeWeb

Editor s Note

The product has shipped, on time. Sounds like the lead paragraph for any one of the articles covered across the GenomeWeb network, but in this case, it’s describing this publication.

We launched last Thursday and spoke with our first customer, a managing director for an Austin, Texas, investment firm responsible for coverage of healthcare, biotech, and medical devices. Previously, he was director of business development for a molecular biology tools company and before that, an equity analyst on Wall Street.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.